Sigma Planning Corp Point Biopharma Global Inc. Transaction History

Sigma Planning Corp

  • $3.22 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$5.6 - $9.5 $26,684 - $45,267
4,765 Added 32.38%
19,480 $133,000
Q1 2022

Apr 20, 2022
SELL
$5.46 - $8.13 $546 - $813
-100 Reduced 0.67%
14,715 $117,000
Q4 2021

Feb 02, 2022
SELL
$4.83 - $9.75 $34,051 - $68,737
-7,050 Reduced 32.24%
14,815 $83,000
Q3 2021

Oct 28, 2021
BUY
$7.42 - $11.26 $162,238 - $246,199
21,865 New
21,865 $168,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email